Fig. 16
From: Persistent luminescence nanoparticles for cancer theranostics application
(Reproduced with permission [130]. Copyright 2020, American Chemical Society)
a Schematic representation of multimodal imaging and combination therapy. b In vivo PersL imaging of 4T1 tumor-bearing mice. c In vitro concentration-dependent cell viabilities of PHFI treated 4T1 cells with different laser irradiations. d Tumor-growth profiles of tumor-bearing mice with different treatment.